MedPath

Effect of selenium on oral inflammatio

Not Applicable
Conditions
Mucositis.
K12.3
Registration Number
IRCT2015010511192N4
Lead Sponsor
Depeuty of Research, Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Patients with diagnosis of oral;nasopharynx or hypopharynx cancer; who recieve at least 5000 centi gray radiation; at lest 2 locations of oral suitable fior radiotherapy
Exclusion criteria: Patients under 18 years old

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mucosistis severity. Timepoint: Bbaseline;first week;second week;Third week;Fourth week; Fifth week. Method of measurement: Clinical examination.
Secondary Outcome Measures
NameTimeMethod
Drug hypersensitivity;Headache. Timepoint: Weekly. Method of measurement: Question from patient.
© Copyright 2025. All Rights Reserved by MedPath